0001950047-23-005879.txt : 20231211 0001950047-23-005879.hdr.sgml : 20231211 20231211163900 ACCESSION NUMBER: 0001950047-23-005879 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 231478643 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Shah Sujal CENTRAL INDEX KEY: 0001588861 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 7575 GATEWAY BLVD., SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 144 1 primary_doc.xml 144 0001588861 XXXXXXXX LIVE 0001042074 CYMABAY THERAPEUTICS, INC. 001-36500 7575 Gateway Blvd, Suite 110 Newark CA 94560 (510) 293-8800 SUJAL A SHAH Officer Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

64865 1297163.78 113403353 12/11/2023 NASDAQ COMMON 12/11/2023 Stock Option Exercise ISSUER N 64865 12/11/2023 Cash N SUJAL A SHAH

7575 Gateway Blvd, Suite 110 Newark CA 94560

Common 11/13/2023 64863 1030630.91 SUJAL A SHAH

7575 Gateway Blvd, Suite 110 Newark CA 94560

Common 10/09/2023 64861 921285.64 12/11/2023 06/28/2023 /s/ Sujal Arun Shah